Skip to main content
. Author manuscript; available in PMC: 2013 Oct 22.
Published in final edited form as: Oral Oncol. 2013 Feb 4;49(5):461–467. doi: 10.1016/j.oraloncology.2012.12.016

Table 2.

Toxicities.

Nonhematologic toxicity Grade 1 Grade 2 Grade 3 Grade 4 Grade 5 Total Grade ≥3
Dermatologic
 Acneiform rash 4 (33%) 6 (50%) 0 0 0 0
Edema
 Facial/neck 3 (25%) 1 (8%) 1 (8%) 0 0 1 (8%)
 Laryngeal 0 0 0 1 (8%) 0 1 (8%)
Constitutional
 Asthenia 2 (17%) 3 (25%) 4 (33%) 1 (8%) 0 5 (42%)
Gastrointestinal
 Oral mucositis 3 (25%) 4 (33%) 0 0 0 0
 Diarrhea 5 (42%) 0 2 (17%) 0 0 2 (17%)
 Peritonitis/infection 0 0 2 (17%) 0 0 2 (17%)
 Anorexia 0 2 (17%) 1 (8%) 0 0 1 (8%)
 Nausea/vomiting 3 (25%) 1 (8%) 0 0 0 0
 Elevated triglycerides 1 (8%) 0 1 (8%) 0 0 1 (8%)
Pulmonary
 Aspiration pneumonia 0 0 1 (8%) 0 0 1 (8%)
 Dyspnea 1 (8%) 0 1 (8%) 2 (17%) 0 3 (25%)
 Pneumonitis 1 (8%) 0 0 0 0 0
 Hypoxia 0 0 0 0 1 (8%) 1 (8%)